{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T11:18:53Z","timestamp":1785410333754,"version":"3.56.0"},"reference-count":160,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005375","name":"Latvian Council of Science","doi-asserted-by":"publisher","award":["LZP-2021\/1-0484"],"award-info":[{"award-number":["LZP-2021\/1-0484"]}],"id":[{"id":"10.13039\/501100005375","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005375","name":"Latvian Council of Science","doi-asserted-by":"publisher","award":["LZP LV_UA \/2025\/3"],"award-info":[{"award-number":["LZP LV_UA \/2025\/3"]}],"id":[{"id":"10.13039\/501100005375","id-type":"DOI","asserted-by":"publisher"}]},{"award":["LZP-2021\/1-0484"],"award-info":[{"award-number":["LZP-2021\/1-0484"]}],"id":[{"id":"https:\/\/ror.org\/02ar66p97","id-type":"ROR","asserted-by":"publisher"}]},{"award":["LZP LV_UA \/2025\/3"],"award-info":[{"award-number":["LZP LV_UA \/2025\/3"]}],"id":[{"id":"https:\/\/ror.org\/02ar66p97","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Background: Persistent high-risk human papillomavirus (hrHPV) infection causes over 99% of cervical precancers and cancers worldwide, with HPV genotype 16 (HPV16) responsible for 50% of the cases. Latvia ranks among the top EU countries for cervical cancer incidence and mortality. In the general Latvian population, 4.2% of women are hrHPV-infected, mostly with HPV16. However, information on the circulating HPV16 isolates is missing. Objectives: To study the genomic variability of the Latvian HPV16 isolates, compare them with HPV16 in Europe and across the globe, reveal features associated with the severity of cervical disease and uncover eventual sequence changes due to the national HPV vaccination. Methods: DNA was extracted from the formalin-fixed paraffin-embedded cervical tissues of women diagnosed with cervical intraepithelial neoplasia (CIN) stages I-III and squamous cell carcinoma (SCC) grades 1\u20133, collected between 2012 and 2024. Samples positive for HPV16 were subjected to whole genome sequencing (WGS) on the Illumina platform (n = 16) or Sanger sequencing of the E6\/E7 coding region (n = 31). A consensus HPV16 sequence was generated, and single nucleotide polymorphisms (SNPs) and eventual amino acid substitutions (AAS) were analysed. Results: Complete genomes of 16 HPV16 variants were reconstructed, with 13 related to the European sublineage A1 and 3 to the sublineage A2 references. Sequences showed high conservation; still 93 non-redundant variants were identified. The highest variability was observed for the capsid protein L2, and the lowest, for oncoprotein E7. The prevalence of SNPs and AAS in the Latvian HPV16 variants, specifically in capsid protein L1, did not increase with time, showing no effect of HPV vaccination. Associations between HPV16 sequence features and severity of cervical disease were limited to AAS E6:L90V, which was significantly more common in SCC grade 2\/3 than in CINII\/III cases (p = 0.015). Conclusions: Highly conserved HPV16 genomes circulating in Latvia harbour a series of unique as well as common nonsynonymous SNPs with respective AAS, with one, AAS E6:L90V, associating with disease severity. No HPV vaccine escape variants were detected. Deciphering complete genomes of HPV16 from CIN and SCC cases in Latvia informs public authorities performing HPV vaccination and is useful for the management of HPV-associated cervical diseases.<\/jats:p>","DOI":"10.3390\/vaccines14060517","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T06:33:44Z","timestamp":1781073224000},"page":"517","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Complete Genomes of Human Papillomavirus Type 16 Viruses Isolated from Cases of Cervical Neoplasia and Squamous Cell Carcinomas Followed in Latvia in 2012\u20132024"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0845-4392","authenticated-orcid":false,"given":"Juris","family":"Jansons","sequence":"first","affiliation":[{"name":"Institute of Microbiology and Virology, Riga Stradins University, LV-1067 Riga, Latvia"},{"name":"National Research and Innovation Institute, LV-1067 Riga, Latvia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7429-5962","authenticated-orcid":false,"given":"Nikita","family":"Zrelovs","sequence":"additional","affiliation":[{"name":"Scientific Laboratory of Molecular Genetics, Riga Stradins University, LV-1007 Riga, Latvia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arta","family":"Spridzane","sequence":"additional","affiliation":[{"name":"Institute of Microbiology and Virology, Riga Stradins University, LV-1067 Riga, Latvia"},{"name":"Latvian Oncology Center, Riga East Clinical University Hospital, LV-1079 Riga, Latvia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-7965-0359","authenticated-orcid":false,"given":"Marija","family":"Nazarenko","sequence":"additional","affiliation":[{"name":"Institute of Microbiology and Virology, Riga Stradins University, LV-1067 Riga, Latvia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5820-1783","authenticated-orcid":false,"given":"Liba","family":"Sokolovska","sequence":"additional","affiliation":[{"name":"Institute of Microbiology and Virology, Riga Stradins University, LV-1067 Riga, Latvia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina","family":"Biserova","sequence":"additional","affiliation":[{"name":"Institute of Microbiology and Virology, Riga Stradins University, LV-1067 Riga, Latvia"},{"name":"Pathology Institute, Pauls Stradins Clinical University Hospital, LV-1002 Riga, Latvia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daira","family":"Krisane","sequence":"additional","affiliation":[{"name":"Pathology Institute, Pauls Stradins Clinical University Hospital, LV-1002 Riga, Latvia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Austra","family":"Breiksa-Vaivode","sequence":"additional","affiliation":[{"name":"Pathology Institute, Pauls Stradins Clinical University Hospital, LV-1002 Riga, Latvia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8168-5969","authenticated-orcid":false,"given":"Daria","family":"Avdoshina","sequence":"additional","affiliation":[{"name":"Institute of Microbiology and Virology, Riga Stradins University, LV-1067 Riga, Latvia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrise","family":"Orlova","sequence":"additional","affiliation":[{"name":"Centrala Laboratorija Ltd., LV-1019 Riga, Latvia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Petrovska","sequence":"additional","affiliation":[{"name":"Centrala Laboratorija Ltd., LV-1019 Riga, Latvia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6417-833X","authenticated-orcid":false,"given":"Serhii","family":"Kalman","sequence":"additional","affiliation":[{"name":"R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, National Academy of Sciences of Ukraine, 03022 Kyiv, Ukraine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Petkov","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, 17177 Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4377-2759","authenticated-orcid":false,"given":"Valery","family":"Ilinsky","sequence":"additional","affiliation":[{"name":"Eligens, Human Genetics, Digital Health, Eligens SIA, LV-2167 Marupe, Latvia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Ilinskaya","sequence":"additional","affiliation":[{"name":"Eligens, Human Genetics, Digital Health, Eligens SIA, LV-2167 Marupe, Latvia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9730-9837","authenticated-orcid":false,"given":"Jurijs","family":"Nazarovs","sequence":"additional","affiliation":[{"name":"Pathology Institute, Pauls Stradins Clinical University Hospital, LV-1002 Riga, Latvia"},{"name":"Department of Pathology, Riga Stradins University, LV-1007 Riga, Latvia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Androniks","family":"Mitildzans","sequence":"additional","affiliation":[{"name":"Latvian Oncology Center, Riga East Clinical University Hospital, LV-1079 Riga, Latvia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9382-2254","authenticated-orcid":false,"given":"Maria","family":"Isaguliants","sequence":"additional","affiliation":[{"name":"Institute of Microbiology and Virology, Riga Stradins University, LV-1067 Riga, Latvia"},{"name":"Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, 17177 Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,9]]},"reference":[{"key":"ref_1","unstructured":"(2025, February 19). Cervical Cancer. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/cervical-cancer."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/ijc.30716","article-title":"Worldwide Burden of Cancer Attributable to HPV by Site, Country and HPV Type","volume":"141","author":"Martel","year":"2017","journal-title":"Int. J. Cancer"},{"key":"ref_3","unstructured":"(2026, March 30). International Human Papillomavirus Reference Center. Available online: https:\/\/www.hpvcenter.se\/."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Kombe Kombe, A.J., Li, B., Zahid, A., Mengist, H.M., Bounda, G.-A., Zhou, Y., and Jin, T. (2021). Epidemiology and Burden of Human Papillomavirus and Related Diseases, Molecular Pathogenesis, and Vaccine Evaluation. Front. Public Health, 8.","DOI":"10.3389\/fpubh.2020.552028"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1080\/01443615.2019.1634030","article-title":"Human Papillomavirus and Cervical Cancer","volume":"40","author":"Okunade","year":"2020","journal-title":"J. Obstet. Gynaecol."},{"key":"ref_6","unstructured":"(2026, March 30). Global Strategy to Accelerate the Elimination of Cervical Cancer as a Public Health Problem. Available online: https:\/\/www.who.int\/publications\/i\/item\/9789240014107."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.virol.2008.11.046","article-title":"Papillomaviruses in the Causation of Human Cancers\u2014A Brief Historical Account","volume":"384","year":"2009","journal-title":"Virology"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","article-title":"Human Papillomavirus Genotype Attribution in Invasive Cervical Cancer: A Retrospective Cross-Sectional Worldwide Study","volume":"11","author":"Sanjose","year":"2010","journal-title":"Lancet Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(19)30298-3","article-title":"Population-Level Impact and Herd Effects Following the Introduction of Human Papillomavirus Vaccination Programmes: Updated Systematic Review and Meta-Analysis","volume":"394","author":"Drolet","year":"2019","journal-title":"Lancet"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2400820","DOI":"10.2807\/1560-7917.ES.2025.30.27.2400820","article-title":"Human Papillomavirus Prevalence in First, Second and Third Cervical Cell Samples from Women HPV-Vaccinated as Girls, Denmark, 2017 to 2024: Data from the Trial23 Cohort Study","volume":"30","author":"Nonboe","year":"2025","journal-title":"Euro Surveill."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Kamzayeva, N., Bapayeva, G., Terzic, M., Primbetov, B., Imankulova, B., Kim, Y., Sultanova, A., Kongrtay, K., Kadroldinova, N., and Ukybassova, T. (2025). Enhancing Cervical Cancer Screening: New Diagnostic Methodologies, Triage, and Risk Stratification in Prevention and Treatment. Life, 15.","DOI":"10.3390\/life15030367"},{"key":"ref_12","unstructured":"Bruni, L., Albero, G., Serrano, B., Mena, M., Collado, J.J., G\u00f3mez, D., Mu\u00f1oz, J., Bosch, F.X., and de Sanjos\u00e9, S. (2025, January 01). ICO\/IARC Information Centre on HPV and Cancer (HPV Information Centre). Human Papillomavirus and Related Diseases in the World. Summary Report. Available online: https:\/\/hpvcentre.net\/statistics\/reports\/XWX.pdf."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1158\/1055-9965.EPI-20-1321","article-title":"The Differential Risk of Cervical Cancer in HPV Vaccinated and Unvaccinated Women: A Mathematical Modelling Study","volume":"30","author":"Naslazi","year":"2021","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1002\/ijc.31409","article-title":"Impacts of Human Papillomavirus Vaccination for Different Populations: A Modeling Study","volume":"143","author":"Baussano","year":"2018","journal-title":"Int. J. Cancer"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1017\/S0950268815002198","article-title":"Prophylactic HPV Vaccination: Past, Present, and Future","volume":"144","author":"Castle","year":"2016","journal-title":"Epidemiol. Infect."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"100836","DOI":"10.1016\/j.eclinm.2021.100836","article-title":"Human Papillomavirus Vaccination Uptake in Low-and Middle-Income Count Ries: A Meta-Analysis","volume":"34","author":"Dorji","year":"2021","journal-title":"eClinicalMedicine"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/CMR.16.1.1-17.2003","article-title":"Human Papillomavirus and Cervical Cancer","volume":"16","author":"Burd","year":"2003","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"West, N., Boz, V., Zanotta, N., Cason, C., Campisciano, G., Casuccio, A., Gianfrilli, D., Fasciana, T.M.A., Capra, G., and Salfa, M.C. (2025). Human Papillomavirus: An Old New History. Pathogens, 14.","DOI":"10.20944\/preprints202509.1506.v1"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1002\/ijc.29651","article-title":"Human Papillomavirus Prevalence and Type-Distribution in Cervical Glandular Neoplasias: Results from a European Multinational Epidemiological Study","volume":"137","author":"Holl","year":"2015","journal-title":"Int. J. Cancer"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/s12985-025-02830-7","article-title":"Trends in HPV-Positive Cervical Cancer Prevalence: A Retrospective Study from 2013 to 2020","volume":"22","author":"Yang","year":"2025","journal-title":"Virol. J."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Vel\u00e1zquez-M\u00e1rquez, N., Paredes-Ju\u00e1rez, G.A., and Vallejo-Ruiz, V. (2024). Progression Pathways of Human Papillomavirus-Associated Cancer. Pathogens Associated with the Development of Cancer in Humans: OMICs, Immunological, and Pathophysiological Studies, Springer Nature.","DOI":"10.1007\/978-3-031-62558-9"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Yu, Y.-Q., Jiang, M.-Y., Dang, L., Feng, R.-M., Bangura, M.S., Chen, W., and Qiao, Y.-L. (2022). Changes in High-Risk HPV Infection Prevalence and Associated Factors in Selected Rural Areas of China: A Multicenter Population-Based Study. Front. Med., 9.","DOI":"10.3389\/fmed.2022.911367"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Tsakogiannis, D., Zografos, E., Tzioga, L., Zografos, C.G., Zagouri, F., and Bletsa, G. (2025). Prevalence and Genotype Distribution of High-Risk HPV Genotypes Among Women in Greece: A Retrospective Analysis of 3500 Women. Cancers, 17.","DOI":"10.3390\/cancers17081267"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s12985-025-02726-6","article-title":"HPV Infection Incidence and Genotype Distribution among Male Patients Visiting Outpatient Departments in Huizhou from 2014 to 2023","volume":"22","author":"Wen","year":"2025","journal-title":"Virol. J."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1158\/1055-9965.EPI-17-0853","article-title":"An Examination of HPV16 Natural Immunity in Men Who Have Sex with Men (MSM) in the HPV in Men (HIM) Study","volume":"27","author":"Beachler","year":"2018","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_26","unstructured":"(2025, July 29). Latvia: Human Papillomavirus and Related Cancers, Fact Sheet 2023. Available online: https:\/\/hpvcentre.net\/statistics\/reports\/LVA_FS.pdf."},{"key":"ref_27","unstructured":"OECD, and European Commission (2025, July 29). EU Country Cancer Profile: Latvia 2025. EU Country Cancer Profiles, Available online: https:\/\/www.oecd.org\/en\/publications\/eu-country-cancer-profile-latvia-2025_f23ce73c-en.html."},{"key":"ref_28","unstructured":"(2026, March 30). State of Vaccine Confidence in the European Union. Available online: https:\/\/health.ec.europa.eu\/system\/files\/2023-02\/2022_confidence_rep_en.pdf."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1093\/eurpub\/ckae075","article-title":"Understanding the High-Risk Human Papillomavirus Prevalence and Associated Factors in the European Country with a High Incidence of Cervical Cancer","volume":"34","author":"Berza","year":"2024","journal-title":"Eur. J. Public Health"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Stasulane, A., Grundmane, J., Sulte, K., Stasulans, J., Cernavska, S., and Smite, L. (2025). Prevalence of Human Papillomavirus Genotypes in Latvia among Women Participating in Cervical Cancer Screening. Front. Oncol., 15.","DOI":"10.3389\/fonc.2025.1584677"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Sokolovska, L., Biserova, K., Spridzane, A., Krisane, D., Dudorova, A., Gebrila, S., Krasovska, I., Perminov, D., Orlova, B., and Petrovska, M. (2026). Persistently High Prevalence of HPV16 and Rising Prevalence of Non-16\/18 HR-HPV Genotypes in Cervical Precancer and Cancer in Latvia in 2016-2024 Shape the Severity of Cervical Disease. Front. Oncol., 15.","DOI":"10.3389\/fonc.2025.1676334"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Berza, N., Stars, I., Zodzika, J., Kivite-Urtane, A., P\u00e4rna, K., Uuskula, A., and Makejeva, D. (2025). Understanding Hesitancy: Barriers to HR-HPV Self-Sampling among Women at High Risk for Cervical Cancer in Latvia. BMC Womens Health, 26.","DOI":"10.1186\/s12905-025-04205-0"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13027-025-00643-5","article-title":"Prophylactic Vaccines against HPV-Caused Cervical Cancer: Novel Vaccines Are Still Demanded","volume":"20","author":"Amiri","year":"2025","journal-title":"Infect. Agents Cancer"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13027-025-00682-y","article-title":"New Mouse Model Based on Adenocarcinoma 4T1 Cells Expressing HPV16 E6 and E7 Applied to Assess the Efficacy of Therapeutic and Prophylactic E6\/E7-Based HPV16 Vaccines","volume":"20","author":"Jansons","year":"2025","journal-title":"Infect. Agents Cancer"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e01176-18","DOI":"10.1128\/JCM.01176-18","article-title":"Clinical and Analytical Evaluation of the Anyplex II HPV HR Detection Assay within the VALGENT-3 Framework","volume":"56","author":"Xu","year":"2018","journal-title":"J. Clin. Microbiol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"105638","DOI":"10.1016\/j.jcv.2023.105638","article-title":"Allplex HPV HR Detection Assay Fulfils All Clinical Performance and Reproducibility Validation Requirements for Primary Cervical Cancer Screening","volume":"170","author":"Cuschieri","year":"2024","journal-title":"J. Clin. Virol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jcv.2016.01.009","article-title":"Clinical Validation of AnyplexTM II HPV HR Detection According to the Guidelines for HPV Test Requirements for Cervical Cancer Screening","volume":"76","author":"Hesselink","year":"2016","journal-title":"J. Clin. Virol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"114435","DOI":"10.1016\/j.jviromet.2021.114435","article-title":"Concordance of AnyplexTM II HPV HR Assays with Reference HPV Assays in Cervical Cancer Screening: Systematic Review","volume":"301","author":"Biazin","year":"2022","journal-title":"J. Virol. Methods"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"rbae123","DOI":"10.1093\/rb\/rbae123","article-title":"Determination of DNA Content as Quality Control in Decellularized Tissues: Challenges and Pitfalls","volume":"11","author":"Philips","year":"2024","journal-title":"Regen. Biomater."},{"key":"ref_40","first-page":"317","article-title":"Analysis of Human Papillomavirus Type 16 E6 Variants in Relation to P53 Codon 72 Polymorphism Genotypes in Cervical Carcinogenesis","volume":"81","author":"Snijders","year":"2000","journal-title":"J. Gen. Virol."},{"key":"ref_41","unstructured":"(2026, March 31). BioEdit 7.7 Download (Free)\u2014BioEdit.Exe. Available online: https:\/\/bioedit.software.informer.com\/7.7\/."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","article-title":"Fast and Accurate Short Read Alignment with Burrows-Wheeler Transform","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","article-title":"The Sequence Alignment\/Map Format and SAMtools","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"ref_44","unstructured":"Seemann, T. (2025, February 19). GitHub\u2014Tseemann\/Samclip: Filter SAM File for Soft and Hard Clipped a Lignments. Available online: https:\/\/github.com\/tseemann\/samclip."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13059-018-1618-7","article-title":"An Amplicon-Based Sequencing Framework for Accurately Measuring Intrah Ost Virus Diversity Using PrimalSeq and iVar","volume":"20","author":"Grubaugh","year":"2019","journal-title":"Genome Biol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.virol.2013.07.018","article-title":"Human Papillomavirus Genome Variants","volume":"445","author":"Burk","year":"2013","journal-title":"Virology"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1093\/molbev\/mst010","article-title":"MAFFT Multiple Sequence Alignment Software Version 7: Improvements in Performance and Usability","volume":"30","author":"Katoh","year":"2013","journal-title":"Mol. Biol. Evol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1093\/molbev\/msu300","article-title":"IQ-TREE: A Fast and Effective Stochastic Algorithm for Estimating Maximum-Likelihood Phylogenies","volume":"32","author":"Nguyen","year":"2015","journal-title":"Mol. Biol. Evol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/nmeth.4285","article-title":"ModelFinder: Fast Model Selection for Accurate Phylogenetic Estimates","volume":"14","author":"Kalyaanamoorthy","year":"2017","journal-title":"Nat. Methods"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1093\/molbev\/mst024","article-title":"Ultrafast Approximation for Phylogenetic Bootstrap","volume":"30","author":"Minh","year":"2013","journal-title":"Mol. Biol. Evol."},{"key":"ref_51","unstructured":"Rambaut, A. (2021, May 10). FigTree v. 1.4.4. Available online: http:\/\/tree.bio.ed.ac.uk\/software\/figtree\/."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/s41597-024-03571-y","article-title":"Exploring and Retrieving Sequence and Metadata for Species across the Tree of Life with NCBI Datasets","volume":"11","author":"Cox","year":"2024","journal-title":"Sci. Data"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"R12","DOI":"10.1186\/gb-2004-5-2-r12","article-title":"Versatile and Open Software for Comparing Large Genomes","volume":"5","author":"Kurtz","year":"2004","journal-title":"Genome Biol."},{"key":"ref_54","unstructured":"(2025, February 26). Available online: https:\/\/github.com\/federicogiorgi\/giorgilab\/tree\/master\/coronannotator."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1093\/bib\/bbx108","article-title":"MAFFT Online Service: Multiple Sequence Alignment, Interactive Sequence Choice and Visualization","volume":"20","author":"Katoh","year":"2019","journal-title":"Brief. Bioinform."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"btac741","DOI":"10.1093\/bioinformatics\/btac741","article-title":"Updated Site Concordance Factors Minimize Effects of Homoplasy and Taxon Sampling","volume":"39","author":"Mo","year":"2023","journal-title":"Bioinformatics"},{"key":"ref_57","unstructured":"(2026, March 30). SNAP: Synonymous Non-Synonymous Analysis Program, Available online: https:\/\/www.hiv.lanl.gov\/content\/sequence\/SNAP\/SNAP.html."},{"key":"ref_58","first-page":"418","article-title":"Simple Methods for Estimating the Numbers of Synonymous and Nonsynonymous Nucleotide Substitutions","volume":"3","author":"Nei","year":"1986","journal-title":"Mol. Biol. Evol."},{"key":"ref_59","first-page":"438","article-title":"The Jukes-Cantor Model of Molecular Evolution","volume":"20","author":"Erickson","year":"2010","journal-title":"Probl. Resour. Issues Math. Undergrad. Stud. PRIMUS"},{"key":"ref_60","unstructured":"(2026, March 31). MEGA\u2014Molecular Evolutionary Genetics Analysis Software. Available online: https:\/\/www.megasoftware.net\/."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1093\/bioinformatics\/btu154","article-title":"CorMut: An R\/Bioconductor Package for Computing Correlated Mutations Based on Selection Pressure","volume":"30","author":"Li","year":"2014","journal-title":"Bioinformatics"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1177\/1740774520941419","article-title":"Non-Adjustment for Multiple Testing in Multi-Arm Trials of Distinct Treatments: Rationale and Justification","volume":"17","author":"Parker","year":"2020","journal-title":"Clin. Trials"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1177\/0962280216664759","article-title":"Recommendations on Multiple Testing Adjustment in Multi-Arm Trials with a Shared Control Group","volume":"27","author":"Howard","year":"2018","journal-title":"Stat. Methods Med. Res."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1002\/sim.2832","article-title":"Chi-Squared and Fisher-Irwin Tests of Two-by-Two Tables with Small Sample Recommendations","volume":"26","author":"Campbell","year":"2007","journal-title":"Stat. Med."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/(SICI)1097-0215(19961021)69:5<364::AID-IJC2>3.0.CO;2-3","article-title":"Human papillomavirus genotype as a predictor of persistence and development of high-grade lesions in women with minor cervical abnormalities","volume":"69","author":"Londesborough","year":"1996","journal-title":"Int. J. Cancer"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0304-3835(00)00457-2","article-title":"Enhanced Oncogenicity of Human Papillomavirus Type 16 (HPV16) Variants in Japanese Population","volume":"156","author":"Matsumoto","year":"2000","journal-title":"Cancer Lett."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/s12985-023-02188-8","article-title":"Genetic Variation of E6 and E7 Genes of Human Papillomavirus Type 16 from Central China","volume":"20","author":"Li","year":"2023","journal-title":"Virol. J."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"890; author reply 891","DOI":"10.1002\/sim.4116","article-title":"The Analysis of 2 \u00d7 2 Contingency Tables--yet Again","volume":"30","author":"Richardson","year":"2011","journal-title":"Stat. Med."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13027-021-00395-y","article-title":"HPV16 E6-Specific T Cell Response and HLA-A Alleles Are Related to the Prognosis of Patients with Cervical Cancer","volume":"16","author":"Cai","year":"2021","journal-title":"Infect. Agents Cancer"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1002\/ijc.32038","article-title":"Genetic Variations in Human Papillomavirus and Cervical Cancer Outcomes","volume":"144","author":"Rader","year":"2019","journal-title":"Int. J. Cancer"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"8761","DOI":"10.1158\/0008-5472.CAN-04-2455","article-title":"Spontaneous Regression of Grade 3 Vulvar Intraepithelial Neoplasia Associated with Human Papillomavirus-16-Specific CD4(+) and CD8(+) T-Cell Responses","volume":"64","author":"Ziol","year":"2004","journal-title":"Cancer Res."},{"key":"ref_72","first-page":"45","article-title":"Human Papillomavirus 16-Specific T Cell Responses in Classic HPV-Related Vulvar Intra-Epithelial Neoplasia. Determination of Strongly Immunogenic Regions from E6 and E7 Proteins","volume":"159","author":"Berville","year":"2010","journal-title":"Clin. Exp. Immunol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1002\/ijc.11332","article-title":"Human Papillomavirus Type 16 E6 Variants and HLA Class II Alleles among Japanese Women with Cervical Cancer","volume":"106","author":"Matsumoto","year":"2003","journal-title":"Int. J. Cancer"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.cell.2017.08.001","article-title":"HPV16 E7 Genetic Conservation Is Critical to Carcinogenesis","volume":"170","author":"Mirabello","year":"2017","journal-title":"Cell"},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Nejo, Y.T., Olaleye, D.O., and Odaibo, G.N. (2019). Molecular Characterisation of Genital Human Papillomavirus among Women in Southwestern, Nigeria. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0224748"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Du, J., Nordfors, C., N\u00e4sman, A., Sobkowiak, M., Romanitan, M., Dalianis, T., and Ramqvist, T. (2012). Human Papillomavirus (HPV) 16 E6 Variants in Tonsillar Cancer in Comparison to Those in Cervical Cancer in Stockholm, Sweden. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0036239"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.molcel.2006.01.024","article-title":"Structural and Functional Analysis of E6 Oncoprotein: Insights in the Molecular Pathways of Human Papillomavirus-Mediated Pathogenesis","volume":"21","author":"Masson","year":"2006","journal-title":"Mol. Cell"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1038\/s41598-022-05995-1","article-title":"Molecular Insights into the Interaction of HPV-16 E6 Variants against MAGI-1 PDZ1 Domain","volume":"12","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1099\/vir.0.82558-0","article-title":"Identification of HLA-DR1- and HLA-DR15-Restricted Human Papillomavirus Type 16 (HPV16) and HPV18 E6 Epitopes Recognized by CD4+ T Cells from Healthy Young Women","volume":"88","author":"Gallagher","year":"2007","journal-title":"J. Gen. Virol."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Jabbar, B., Rafique, S., Salo-Ahen, O.M.H., Ali, A., Munir, M., Idrees, M., Mirza, M.U., Vanmeert, M., Shah, S.Z., and Jabbar, I. (2018). Antigenic Peptide Prediction From E6 and E7 Oncoproteins of HPV Types 16 and 18 for Therapeutic Vaccine Design Using Immunoinformatics and MD Simulation Analysis. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.03000"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"e01401","DOI":"10.1128\/spectrum.01401-22","article-title":"Deep Sequencing of HPV16 E6 Region Reveals Unique Mutation Pattern of HPV16 and Predicts Cervical Cancer","volume":"10","author":"Ai","year":"2022","journal-title":"Microbiol. Spectr."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"5420","DOI":"10.4049\/jimmunol.167.9.5420","article-title":"Antigen Processing Defects in Cervical Carcinomas Limit the Presentation of a CTL Epitope from Human Papillomavirus 16 E6","volume":"167","author":"Evans","year":"2001","journal-title":"J. Immunol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/jmv.25618","article-title":"Genetic Variability and Functional Implication of HPV16 from Cervical Intraepithelial Neoplasia in Shanghai Women","volume":"92","author":"Zhao","year":"2020","journal-title":"J. Med. Virol."},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Yuan, H., Yan, Z., Gan, J., Di, X., Qiu, Y., and Xu, H. (2024). Phylogenetic Analysis and Antigenic Epitope Prediction for E6 and E7 of Alpha-Papillomavirus 9 in Taizhou, China. BMC Genom., 25.","DOI":"10.1186\/s12864-024-10411-1"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12985-021-01728-4","article-title":"The Polymorphism Analysis and Epitope Predicted of Alphapapillomavirus 9 E6 in Sichuan, China","volume":"19","author":"He","year":"2022","journal-title":"Virol. J."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Dai, M.-Z., Qiu, Y., Di, X.-H., Shi, W.-W., and Xu, H.-H. (2021). Association of Cervical Carcinogenesis Risk with HPV16 E6 and E7 Variants in the Taizhou Area, China. BMC Cancer, 21.","DOI":"10.1186\/s12885-021-08531-y"},{"key":"ref_87","first-page":"1003","article-title":"Patterns of CD8 T-Cell Epitopes within the Human Papillomavirus Type 16 (HPV 16) E6 Protein among Young Women Whose HPV 16 Infection Has Become Undetectable","volume":"12","author":"Nakagawa","year":"2005","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1006\/viro.1995.1511","article-title":"Mutational Analysis of Human Papillomavirus Type 16 E6 Protein: Transforming Function for Human Cells and Degradation of P53 in Vitro","volume":"212","author":"Nakagawa","year":"1995","journal-title":"Virology"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.str.2012.02.001","article-title":"Solution Structure Analysis of the HPV16 E6 Oncoprotein Reveals a Self-Association Mechanism Required for E6-Mediated Degradation of P53","volume":"20","author":"Zanier","year":"2012","journal-title":"Structure"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/onc.2008.422","article-title":"A Single-Codon Mutation Converts HPV16 E6 Oncoprotein into a Potential Tumor Suppressor, Which Induces P53-Dependent Senescence of HPV-Positive HeLa Cervical Cancer Cells","volume":"28","author":"Ristriani","year":"2009","journal-title":"Oncogene"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nature16481","article-title":"Structure of the E6\/E6AP\/P53 Complex Required for HPV-Mediated Degradation of P53","volume":"529","author":"Ruiz","year":"2016","journal-title":"Nature"},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Messa, L., Celegato, M., Bertagnin, C., Mercorelli, B., Alvisi, G., Banks, L., Pal\u00f9, G., and Loregian, A. (2021). The Dimeric Form of HPV16 E6 Is Crucial to Drive YAP\/TAZ Upregulation through the Targeting of hScrib. Cancers, 13.","DOI":"10.3390\/cancers13164083"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.imlet.2016.09.013","article-title":"Identification of the Impact on T- and B- Cell Epitopes of Human Papillomavirus Type-16 E6 and E7 Variant in Southwest China","volume":"181","author":"Chenzhang","year":"2017","journal-title":"Immunol. Lett."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1126\/science.1229934","article-title":"Structural Basis for Hijacking of Cellular LxxLL Motifs by Papillomavirus E6 Oncoproteins","volume":"339","author":"Zanier","year":"2013","journal-title":"Science"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"6020","DOI":"10.1038\/s41598-018-24470-4","article-title":"A Quantitative LumiFluo Assay to Test Inhibitory Compounds Blocking P53 Degradation Induced by Human Papillomavirus Oncoprotein E6 in Living Cells","volume":"8","author":"Messa","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/CJI.0000000000000156","article-title":"DNA Vaccine Encoding HPV16 Oncogenes E6 and E7 Induces Potent Cell-Mediated and Humoral Immunity Which Protects in Tumor Challenge and Drives E7-Expressing Skin Graft Rejection","volume":"40","author":"Chandra","year":"2017","journal-title":"J. Immunother."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1016\/j.vaccine.2009.11.069","article-title":"DNA Vaccine against Human Papillomavirus Type 16: Modifications of the E6 Oncogene","volume":"28","author":"Smahel","year":"2010","journal-title":"Vaccine"},{"key":"ref_98","unstructured":"(2026, March 31). E6 Protein E6*; Transforming Protein E6 [Human Papillomavirus 16]\u2014Gene\u2014NCBI, Available online: https:\/\/www.ncbi.nlm.nih.gov\/gene\/1489078."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jviromet.2015.03.008","article-title":"Identification of Human Papillomavirus-16 E6 Variation in Cervical Cancer and Their Impact on T and B Cell Epitopes","volume":"218","author":"Kumar","year":"2015","journal-title":"J. Virol. Methods"},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Venselaar, H., te Beek, T.A., Kuipers, R.K., Hekkelman, M.L., and Vriend, G. (2010). Protein Structure Analysis of Mutations Causing Inheritable Diseases. An e-Science Approach with Life Scientist Friendly Interfaces. BMC Bioinform., 11.","DOI":"10.1186\/1471-2105-11-548"},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Qmichou, Z., Khyatti, M., Berraho, M., Ennaji, M.M., Benbacer, L., Nejjari, C., Benjaafar, N., Benider, A., Attaleb, M., and El Mzibri, M. (2013). Analysis of Mutations in the E6 Oncogene of Human Papillomavirus 16 in Cervical Cancer Isolates from Moroccan Women. BMC Infect. Dis., 13.","DOI":"10.1186\/1471-2334-13-378"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/CJI.0b013e318279652e","article-title":"Human Papillomavirus Type 16 E6\/E7-Specific Cytotoxic T Lymphocytes for Adoptive Immunotherapy of HPV-Associated Malignancies","volume":"36","author":"Ramos","year":"2013","journal-title":"J. Immunother."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1128\/CVI.00404-07","article-title":"Memory T Cells Specific for Novel Human Papillomavirus Type 16 (HPV16) E6 Epitopes in Women Whose HPV16 Infection Has Become Undetectable","volume":"15","author":"Wang","year":"2008","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"4509","DOI":"10.1128\/jvi.70.7.4509-4516.1996","article-title":"High-Risk Human Papillomavirus E6 Protein Has Two Distinct Binding Sites within P53, of Which Only One Determines Degradation","volume":"70","author":"Li","year":"1996","journal-title":"J. Virol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1128\/JVI.00751-11","article-title":"P53 Degradation Activity, Expression, and Subcellular Localization of E6 Proteins from 29 Human Papillomavirus Genotypes","volume":"86","author":"Gagnon","year":"2012","journal-title":"J. Virol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1128\/JVI.77.4.2330-2337.2003","article-title":"Nuclear Entry of High-Risk Human Papillomavirus Type 16 E6 Oncoprotein Occurs via Several Pathways","volume":"77","author":"Moroianu","year":"2003","journal-title":"J. Virol."},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Shibata, T., Shah, S., Evans, T., Coleman, H., Lieblong, B.J., Spencer, H.J., Quick, C.M., Sasagawa, T., Stephens, O.W., and Peterson, E. (2021). Expansion of Human Papillomavirus-Specific T Cells in Periphery and Cervix in a Therapeutic Vaccine Recipient Whose Cervical High-Grade Squamous Intraepithelial Lesion Regressed. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.645299"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1128\/JCM.02202-07","article-title":"Human Papillomavirus Type 16 Variant Analysis of E6, E7, and L1 Genes and Long Control Region in Biopsy Samples from Cervical Cancer Patients in North India","volume":"46","author":"Pande","year":"2008","journal-title":"J. Clin. Microbiol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1054\/bjoc.2000.1247","article-title":"Uneven Distribution of HPV 16 E6 Prototype and Variant (L83V) Oncoprotein in Cervical Neoplastic Lesions","volume":"83","author":"Andersson","year":"2000","journal-title":"Br. J. Cancer"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/S0140-6736(05)61263-9","article-title":"Risk of Cervical Cancer and Geographical Variations of Human Papillomavirus 16 E6 Polymorphisms","volume":"352","author":"Zehbe","year":"1998","journal-title":"Lancet"},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Sun, Z., Lu, Z., Liu, J., Wang, G., Zhou, W., Yang, L., Liu, C., Wang, B., and Ruan, Q. (2013). Genetic Variations of E6 and Long Control Region of Human Papillomavirus Type 16 from Patients with Cervical Lesion in Liaoning, China. BMC Cancer, 13.","DOI":"10.1186\/1471-2407-13-459"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1158\/1055-9965.EPI-05-0864","article-title":"Increased Risk for Cervical Disease Progression of French Women Infected with the Human Papillomavirus Type 16 E6-350G Variant","volume":"15","author":"Grodzki","year":"2006","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"e004790","DOI":"10.1136\/jitc-2022-004790","article-title":"Identification of Novel HLA-A*11:01-Restricted HPV16 E6\/E7 Epitopes and T-Cell Receptors for HPV-Related Cancer Immunotherapy","volume":"10","author":"Xiong","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S0198-8859(03)00033-8","article-title":"Association between Human Papillomavirus 16 E6 Variants and Human Leukocyte Antigen Class I Polymorphism in Cervical Cancer of Swedish Women","volume":"64","author":"Zehbe","year":"2003","journal-title":"Hum. Immunol."},{"key":"ref_115","unstructured":"Bonsack, M. (2025, July 29). Identification and Biological Validation of HPV16 E6\/E7-Derived T Cell Target Epitopes and Their Use for Performance Assessment of MHC Class I Binding Predictors. Available online: https:\/\/archiv.ub.uni-heidelberg.de\/volltextserver\/27654\/."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"6987","DOI":"10.1128\/jvi.70.10.6987-6993.1996","article-title":"Natural Variants of the Human Papillomavirus Type 16 E6 Protein Differ in Their Abilities to Alter Keratinocyte Differentiation and to Induce P53 Degradation","volume":"70","author":"Ching","year":"1996","journal-title":"J. Virol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.virol.2008.09.036","article-title":"Human Papillomavirus 16 E6 Variants Differ in Their Dysregulation of Human Keratinocyte Differentiation and Apoptosis","volume":"383","author":"Zehbe","year":"2009","journal-title":"Virology"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1134\/S0026893324700213","article-title":"Amino Acid Substitution Patterns in the E6 and E7 Proteins of HPV Type 16: Phylogeography and Evolution","volume":"58","author":"Zelenova","year":"2024","journal-title":"Mol. Biol."},{"key":"ref_119","unstructured":"(2025, February 19). Genus: Alphapapillomavirus | ICTV. Available online: https:\/\/ictv.global\/report\/chapter\/papillomaviridae\/papillomaviridae\/alphapapillomavirus."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0042-6822(85)90214-4","article-title":"Human Papillomavirus Type 16 DNA Sequence","volume":"145","author":"Seedorf","year":"1985","journal-title":"Virology"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1038\/s41467-022-30190-1","article-title":"Long-Read Sequencing Unveils High-Resolution HPV Integration and Its Oncogenic Progression in Cervical Cancer","volume":"13","author":"Zhou","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1099\/jgv.0.001072","article-title":"ICTV Virus Taxonomy Profile: Papillomaviridae","volume":"99","author":"Chen","year":"2018","journal-title":"J. Gen. Virol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0140-6736(20)30068-4","article-title":"Impact of HPV Vaccination and Cervical Screening on Cervical Cancer Elimination: A Comparative Modelling Analysis in 78 Low-Income and Lower-Middle-Income Countries","volume":"395","author":"Brisson","year":"2020","journal-title":"Lancet"},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"Cheng, L., Wang, Y., and Du, J. (2020). Human Papillomavirus Vaccines: An Updated Review. Vaccines, 8.","DOI":"10.3390\/vaccines8030391"},{"key":"ref_125","doi-asserted-by":"crossref","unstructured":"Mcbride, A.A., and Porter, S.S. (2019). Human Papillomaviruses (Papillomaviridae). Reference Module in Life Sciences, Elsevier.","DOI":"10.1016\/B978-0-12-814515-9.00018-7"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"144682","DOI":"10.1016\/j.gene.2020.144682","article-title":"HPV16 L1 Diversity and Its Potential Impact on the Vaccination-Induced Immunity","volume":"747","author":"Kassal","year":"2020","journal-title":"Gene"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.virusres.2006.07.012","article-title":"A Deletion and Point Mutation Study of the Human Papillomavirus Type 16 Major Capsid Gene","volume":"122","author":"Varsani","year":"2006","journal-title":"Virus Res."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"145533","DOI":"10.1016\/j.gene.2021.145533","article-title":"Worldwide Genetic Variations in High-Risk Human Papillomaviruses Capsid L1 Gene and Their Impact on Vaccine Efficiency","volume":"782","author":"Oumeslakht","year":"2021","journal-title":"Gene"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.meegid.2013.05.013","article-title":"Amino Acid Sequence Diversity of the Major Human Papillomavirus Capsid Protein: Implications for Current and next Generation Vaccines","volume":"18","author":"Ahmed","year":"2013","journal-title":"Infect. Genet. Evol."},{"key":"ref_130","doi-asserted-by":"crossref","unstructured":"van Eer, K., Dzebisasjvili, T., Steenbergen, R.D.M., and King, A.J. (2024). Comparative Analysis of HPV16 Variants in the Untranslated Regulatory Region, L1, and E6 Genes among Vaccinated and Unvaccinated Young Women: Assessing Vaccine Efficacy and Viral Diversity. Viruses, 16.","DOI":"10.3390\/v16091381"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.virol.2013.04.017","article-title":"L2, the Minor Capsid Protein of Papillomavirus","volume":"445","author":"Wang","year":"2013","journal-title":"Virology"},{"key":"ref_132","doi-asserted-by":"crossref","unstructured":"Tsakogiannis, D., Nikolaidis, M., Zagouri, F., Zografos, E., Kottaridi, C., Kyriakopoulou, Z., Tzioga, L., Markoulatos, P., Amoutzias, G.D., and Bletsa, G. (2022). Mutation Profile of HPV16 L1 and L2 Genes in Different Geographic Areas. Viruses, 15.","DOI":"10.3390\/v15010141"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"5512","DOI":"10.1002\/jmv.27978","article-title":"Longitudinal Follow-up of HPV16 Sequence after Cervical Infection: Low Intrahost Variation and No Correlation with Clinical Evolution","volume":"94","author":"Debernardi","year":"2022","journal-title":"J. Med. Virol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"djw100","DOI":"10.1093\/jnci\/djw100","article-title":"HPV16 Sublineage Associations With Histology-Specific Cancer Risk Usin g HPV Whole-Genome Sequences in 3200 Women","volume":"108","author":"Mirabello","year":"2016","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_135","doi-asserted-by":"crossref","unstructured":"Rana, A., Yilmaz, G., Biswas-Fiss, E.E., and Biswas, S. (2025). Mechanisms of Viral DNA Replication of Human Papillomavirus: E2 Protein-Dependent Recruitment of E1 DNA Helicase to the Origin of DNA Replication. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26094333"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1365-2443.2010.01458.x","article-title":"Rolling Circle Replication of Human Papillomavirus Type 16 DNA in Epithelial Cell Extracts","volume":"16","author":"Kanda","year":"2011","journal-title":"Genes Cells"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s00705-013-1790-8","article-title":"Nucleotide Polymorphisms of the Human Papillomavirus 16 E1 Gene","volume":"159","author":"Tsakogiannis","year":"2014","journal-title":"Arch. Virol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.7150\/ijms.34279","article-title":"Human Papillomavirus Type 16 E1 Mutations Associated with Cervical Cancer in a Han Chinese Population","volume":"16","author":"Yao","year":"2019","journal-title":"Int. J. Med. Sci."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1017\/erm.2021.18","article-title":"Genetic Variability of the HPV16 Early Genes and LCR. Present and Future Perspectives","volume":"23","author":"Bletsa","year":"2021","journal-title":"Expert. Rev. Mol. Med."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"110387","DOI":"10.1016\/j.virol.2024.110387","article-title":"The Functions of Papillomavirus E2 Proteins","volume":"603","author":"Morgan","year":"2025","journal-title":"Virology"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1054\/bjoc.2001.1695","article-title":"Variation in the E2-Binding Domain of HPV 16 Is Associated with High-Grade Squamous Intraepithelial Lesions of the Cervix","volume":"84","author":"Giannoudis","year":"2001","journal-title":"Br. J. Cancer"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.annonc.2022.03.005","article-title":"Genetic Variation within the Human Papillomavirus Type 16 Genome Is Associated with Oropharyngeal Cancer Prognosis","volume":"33","author":"Faden","year":"2022","journal-title":"Ann. Oncol."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"3828","DOI":"10.1158\/0008-5472.CAN-08-3099","article-title":"Disruption of the E2 Gene Is a Common and Early Event in the Natural History of Cervical Human Papillomavirus Infection: A Longitudinal Cohort Study","volume":"69","author":"Collins","year":"2009","journal-title":"Cancer Res."},{"key":"ref_144","doi-asserted-by":"crossref","unstructured":"Porter, V.L., and Marra, M.A. (2022). The Drivers, Mechanisms, and Consequences of Genome Instability in HPV-Driven Cancers. Cancers, 14.","DOI":"10.3390\/cancers14194623"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1136\/mp.53.4.201","article-title":"HPV-16 E2 Gene Disruption and Sequence Variation in CIN 3 Lesions and Invasive Squamous Cell Carcinomas of the Cervix: Relation to Numerical Chromosome Abnormalities","volume":"53","author":"Graham","year":"2000","journal-title":"Mol. Pathol."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"6732","DOI":"10.1128\/JVI.79.11.6732-6740.2005","article-title":"Role of the E1\u2227E4 Protein in the Differentiation-Dependent Life Cycle of Human Papillomavirus Type 31","volume":"79","author":"Wilson","year":"2005","journal-title":"J. Virol."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1128\/JVI.78.2.821-833.2004","article-title":"Functional Analysis of the Human Papillomavirus Type 16 E1\u2227E4 Protein Provides a Mechanism for In Vivo and In Vitro Keratin Filament Reorganization","volume":"78","author":"Wang","year":"2004","journal-title":"J. Virol."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1128\/JVI.77.5.2832-2842.2003","article-title":"Quantitative Role of the Human Papillomavirus Type 16 E5 Gene during the Productive Stage of the Viral Life Cycle","volume":"77","author":"Genther","year":"2003","journal-title":"J. Virol."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.virol.2013.05.006","article-title":"The E5 Proteins","volume":"445","author":"DiMaio","year":"2013","journal-title":"Virology"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1475-2867-6-19","article-title":"Analyses of Variant Human Papillomavirus Type-16 E5 Proteins for Their Ability to Induce Mitogenesis of Murine Fibroblasts","volume":"6","author":"Nath","year":"2006","journal-title":"Cancer Cell Int."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"7014","DOI":"10.1128\/JVI.79.11.7014-7023.2005","article-title":"Diversifying Selection in Human Papillomavirus Type 16 Lineages Based on Complete Genome Analyses","volume":"79","author":"Chen","year":"2005","journal-title":"J. Virol."},{"key":"ref_152","doi-asserted-by":"crossref","unstructured":"Alsanea, M., Alsaleh, A., Obeid, D., Alhadeq, F., Alahideb, B., and Alhamlan, F. (2022). Genetic Variability in the E6, E7, and L1 Genes of Human Papillomavirus Types 16 and 18 among Women in Saudi Arabia. Viruses, 15.","DOI":"10.3390\/v15010109"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1007\/s13337-021-00727-x","article-title":"Genetic Analysis of Human Papilloma Virus 16 E6\/E7 Variants Obtained from Cervical Cancer Cases in Chhattisgarh, a Central State of India","volume":"32","author":"Negi","year":"2021","journal-title":"Virusdisease"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1002\/jmv.27359","article-title":"Genetic Variation in the E6 and E7 Genes of Human Papillomavirus Type 16 in Northeastern Argentina","volume":"94","author":"Totaro","year":"2022","journal-title":"J. Med. Virol."},{"key":"ref_155","doi-asserted-by":"crossref","unstructured":"Rich, R.R., Fleisher, T.A., and Weyand, C.M. (2008). Immune Responses to Viruses. Clinical Immunology. Principles and Practice, Mosby.","DOI":"10.1016\/B978-0-323-04404-2.10001-6"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"4367","DOI":"10.1007\/s00262-023-03571-8","article-title":"HPV-Associated Head and Neck Cancer Is Characterized by Distinct Profiles of CD8+ T Cells and Myeloid-Derived Suppressor Cells","volume":"72","author":"Kansy","year":"2023","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1158\/1535-7163.MCT-15-0742","article-title":"Protection against HPV-16-Associated Tumors Requires the Activation of CD8+ Effector Memory T Cells and the Control of Myeloid-Derived Suppressor Cells","volume":"15","author":"Diniz","year":"2016","journal-title":"Mol. Cancer Ther."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s00239-002-2344-y","article-title":"Evidence of Diversifying Selection in Human Papillomavirus Type 16 E6 But Not E7 Oncogenes","volume":"55","author":"DeFilippis","year":"2002","journal-title":"J. Mol. Evol."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.3892\/or.2013.2281","article-title":"Degradation of P53 by Natural Variants of the E6 Protein of Human Papillomavirus Type 16","volume":"29","author":"Yi","year":"2013","journal-title":"Oncol. Rep."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"100800","DOI":"10.1016\/j.patter.2023.100800","article-title":"Understanding the host-pathogen evolutionary balance through Gaussian process modeling of SARS-CoV-2","volume":"4","author":"Loguercio","year":"2023","journal-title":"Patterns"}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/14\/6\/517\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T04:11:23Z","timestamp":1781669483000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/14\/6\/517"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,9]]},"references-count":160,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["vaccines14060517"],"URL":"https:\/\/doi.org\/10.3390\/vaccines14060517","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,9]]}}}